Zimmer and NuVasive Join MedAccred Platform
#industry #news #UK #2024 #insights #zenopa #recruitment #Zimmer and #NuVasive Join #MedAccred #Platform #medical #device #accreditation #manufacturing #consensus
Source: zenopa.com
Page 9 - Roche Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Roche Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roche Diagnostics Today - Breaking & Trending Today
Weekly Money FM Podcasts: Will the AI bubble burst? If so, how soon?
Check out Money FM's best weekly podcasts. Read more at straitstimes.com.
Source: straitstimes.com
Promising pathways to simplified Alzheimer's
<p>The Global Alzheimer’s Platform Foundation<em><sup>®</sup></em>, (GAP) is releasing the first results from the Bio-Hermes-001 Study. This study in over 1000 community-based participants from throughout the US compared the results of blood and digital biomarkers with brain amyloid PET scans or cerebrospinal fluid assays. The study<em> </em>revealed a strong correlation between several blood tests, particularly p-tau 217, with the presence of amyloid plaques in the brain, a diagnostic hallmark of Alzheimer’s disease (AD). T...
Source: eurekalert.org
Bio-Hermes data reveals strong correlation between blood biomarkers and Alzheimer's amyloid plaques
The Global Alzheimer's Platform Foundation, (GAP) is releasing the first results from the Bio-Hermes-001 Study.
Source: news-medical.net
ASA: No Drop in Recurrent Stroke Seen With Apixaban After Cryptogenic Stroke
For patients with recent cryptogenic stroke and evidence of atrial cardiopathy, the risk for recurrent stroke is not reduced with apixaban.
Source: neurologyadvisor.com